STTR PHASE II - PATTERNED, RESPONSIVE CELLULAR THERAPIES USING NOVEL MAMMALIAN CELLULAR REGULATOR SYSTEMS
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- HR001121C0142
- Contractor
- Awarding agency
- Department of Defense
- Sub-agency / office
- Defense Advanced Research Projects Agency
- Award amount
- $500,000
- Period of performance
- Jun 15, 2021 – Jul 1, 2023
- NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- MA
Public award description
STTR PHASE II - PATTERNED, RESPONSIVE CELLULAR THERAPIES USING NOVEL MAMMALIAN CELLULAR REGULATOR SYSTEMS
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.
Related intelligence
- Agency: Department of Defense
- PSC AC11 — Product Service Code AC11
- Federal market intelligence software